• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内吞的CCR7及其配体的相反命运:再循环与降解。

Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation.

作者信息

Otero Carolina, Groettrup Marcus, Legler Daniel F

机构信息

Biotechnology Institute Thurgau, University of Konstanz, Konstanzerstrasse 19, CH-8274 Tägerwilen, Switzerland.

出版信息

J Immunol. 2006 Aug 15;177(4):2314-23. doi: 10.4049/jimmunol.177.4.2314.

DOI:10.4049/jimmunol.177.4.2314
PMID:16887992
Abstract

The chemokine receptor CCR7 and its ligands CCL19 and CCL21 play a crucial role for the homing of lymphocytes and dendritic cells to secondary lymphoid tissues. Nevertheless, how CCR7 senses the gradient of chemokines and how migration is terminated are poorly understood. In this study, we demonstrate that CCR7(-GFP) is endocytosed into early endosomes containing transferrin receptor upon CCL19 binding, but less upon CCL21 triggering. Internalization of CCR7 was independent of lipid rafts but relied on dynamin and Eps15 and was inhibited by hypertonic sucrose, suggesting clathrin-dependent endocytosis. After chemokine removal, internalized CCR7 recycled back to the plasma membrane and was able to mediate migration again. In contrast, internalized CCL19 was sorted to lysosomes for degradation, showing opposite fate for endocytosed CCR7 and its ligand.

摘要

趋化因子受体CCR7及其配体CCL19和CCL21对于淋巴细胞和树突状细胞归巢至二级淋巴组织起着关键作用。然而,CCR7如何感知趋化因子梯度以及迁移如何终止仍知之甚少。在本研究中,我们证明CCR7(-GFP)在与CCL19结合后会被内吞至含有转铁蛋白受体的早期内体中,但在CCL21触发时内吞较少。CCR7的内化不依赖于脂筏,但依赖于发动蛋白和Eps15,并受到高渗蔗糖的抑制,提示为网格蛋白依赖的内吞作用。趋化因子去除后,内化的CCR7循环回到质膜并能够再次介导迁移。相反,内化的CCL19被分选至溶酶体进行降解,显示出内化的CCR7及其配体的相反命运。

相似文献

1
Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation.内吞的CCR7及其配体的相反命运:再循环与降解。
J Immunol. 2006 Aug 15;177(4):2314-23. doi: 10.4049/jimmunol.177.4.2314.
2
Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.在CCL19而非CCL21连接后,抑制蛋白3介导CCR7的内吞作用。
J Immunol. 2008 Oct 1;181(7):4723-32. doi: 10.4049/jimmunol.181.7.4723.
3
Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.人淋巴结与慢性炎症皮肤中DC-Lamp+成熟树突状细胞CCL19的差异表达。
J Pathol. 2003 Jan;199(1):98-106. doi: 10.1002/path.1255.
4
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2.CCL19/CCL21触发的树突状细胞信号转导和迁移需要前列腺素E2。
Blood. 2004 Mar 1;103(5):1595-601. doi: 10.1182/blood-2003-05-1643. Epub 2003 Oct 30.
5
Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.CC趋化因子受体7的两种内源性配体介导的差异脱敏、受体磷酸化、β抑制蛋白募集及ERK1/2激活
J Biol Chem. 2004 May 28;279(22):23214-22. doi: 10.1074/jbc.M402125200. Epub 2004 Mar 30.
6
The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro.趋化因子受体CCX-CKR在体外介导对CCL19的有效清除。
Eur J Immunol. 2006 Jul;36(7):1904-16. doi: 10.1002/eji.200535716.
7
CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities.CCR7配体可诱导成熟树突状细胞发生快速内吞作用,并伴随Cdc42和Rac活性上调。
Blood. 2003 Jun 15;101(12):4923-9. doi: 10.1182/blood-2002-11-3474. Epub 2003 Feb 27.
8
Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7.二级淋巴组织趋化因子是CC趋化因子受体CCR7的功能性配体。
J Biol Chem. 1998 Mar 20;273(12):7118-22. doi: 10.1074/jbc.273.12.7118.
9
The multiple personalities of the chemokine receptor CCR7 in dendritic cells.树突状细胞中趋化因子受体CCR7的多重特性
J Immunol. 2006 May 1;176(9):5153-9. doi: 10.4049/jimmunol.176.9.5153.
10
Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.CCR7 配体通过共存在趋化因子场中对 T 淋巴细胞的迁移进行组合指导。
PLoS One. 2011 Mar 25;6(3):e18183. doi: 10.1371/journal.pone.0018183.

引用本文的文献

1
Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis.视紫质抑制趋化因子受体7的降解,以引导类风湿性关节炎中II型胶原刺激的树突状细胞迁移。
Acta Pharm Sin B. 2025 Mar;15(3):1626-1642. doi: 10.1016/j.apsb.2025.02.004. Epub 2025 Feb 11.
2
Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions.芳基硫酸酯酶和神经氨酸酶通过去除关键静电相互作用来调节趋化因子与 CCR5 的结合。
Sci Rep. 2024 Jan 2;14(1):292. doi: 10.1038/s41598-023-50944-1.
3
Altered Tumor Necrosis Factor Response in Neurologic Postacute SARS-CoV-2 Syndrome.
神经急性 SARS-CoV-2 综合征中肿瘤坏死因子反应改变。
J Interferon Cytokine Res. 2023 Jul;43(7):307-313. doi: 10.1089/jir.2023.0051. Epub 2023 Jun 29.
4
Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.肝素特异性结合趋化因子 CCL21 的碱性 BBXB 基序来定义 CCR7 信号。
Int J Mol Sci. 2023 Jan 14;24(2):1670. doi: 10.3390/ijms24021670.
5
Shifting CCR7 towards Its Monomeric Form Augments CCL19 Binding and Uptake.趋化因子受体 7 向单体形式转变增强了 CCL19 的结合和摄取。
Cells. 2022 Apr 25;11(9):1444. doi: 10.3390/cells11091444.
6
New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases.CCR7信号在树突状细胞迁移和炎症性疾病中的新见解
Front Pharmacol. 2022 Feb 25;13:841687. doi: 10.3389/fphar.2022.841687. eCollection 2022.
7
Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications.重新思考脑转移中的趋化因子级联反应:预防和治疗意义。
Semin Cancer Biol. 2022 Nov;86(Pt 3):914-930. doi: 10.1016/j.semcancer.2021.12.009. Epub 2021 Dec 27.
8
The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent.激活的 M-CSF 诱导的人单核细胞来源的巨噬细胞的基因特征依赖于 IL-10。
J Innate Immun. 2022;14(3):243-256. doi: 10.1159/000519305. Epub 2021 Oct 20.
9
Evolution of the Tumor Microenvironment toward Immune-Suppressive Seclusion during Brain Metastasis of Breast Cancer: Implications for Targeted Therapy.乳腺癌脑转移过程中肿瘤微环境向免疫抑制隔离状态的演变:对靶向治疗的启示
Cancers (Basel). 2021 Sep 29;13(19):4895. doi: 10.3390/cancers13194895.
10
Simulating CXCR5 Dynamics in Complex Tissue Microenvironments.模拟复杂组织微环境中的 CXCR5 动力学。
Front Immunol. 2021 Sep 7;12:703088. doi: 10.3389/fimmu.2021.703088. eCollection 2021.